http://www.mmm-online.com/offlabel/topic/8603/ Articles tagged with Off-label from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no HPV vaccine price cut; Merck files new allergy med with FDA; GSK pursues online transparency; Walgreens ready for greater nurse autonomy; Epocrates ranks high among docs with tablets. http://www.mmm-online.com/business-briefs-merck-gsk-novo-walgreen-epocrates-doximity/article/292622/ Thu, 09 May 2013 14:56:06 GMT HPV vaccine price cut; Merck files new allergy med with FDA; GSK pursues online transparency; Walgreens ready for greater nurse autonomy; Epocrates ranks high among docs with tablets. MMM It was an all-in-one news day for the drug maker which, by the way, saw sales rise 2% for the first quarter, compared to the same period last year. http://www.mmm-online.com/novartis-lawsuits-layoffs-and-by-the-way-earnings/article/290399/ Wed, 24 Apr 2013 19:38:13 GMT It was an all-in-one news day for the drug maker which, by the way, saw sales rise 2% for the first quarter, compared to the same period last year. MMM Endo gets a new president, Allergan settles a Botox case http://www.mmm-online.com/business-briefs-endo-allergan/article/282090/ Wed, 27 Feb 2013 16:21:45 GMT Endo gets a new president, Allergan settles a Botox case MMM HHS wants input for its TXT4Tots childhood advice program, Gilead releases some Hep. C clinical trial data, and Shire settles with the DOJ over disputed marketing practices. http://www.mmm-online.com/business-briefs-gilead-shire-the-medicines-co-hhs/article/278976/ Mon, 04 Feb 2013 19:21:27 GMT HHS wants input for its TXT4Tots childhood advice program, Gilead releases some Hep. C clinical trial data, and Shire settles with the DOJ over disputed marketing practices. MMM An expert witness in a 2008 lawsuit highlights holes in clinical data, and finds that corporate and published trial data do not necessarily correspond. http://www.mmm-online.com/researcher-takes-aim-at-clashing-drug-data/article/278467/ Thu, 31 Jan 2013 19:11:24 GMT An expert witness in a 2008 lawsuit highlights holes in clinical data, and finds that corporate and published trial data do not necessarily correspond. MMM Amgen "marketed the spread" between the price practices pay for Aranesp and that patients pay as a means of driving sales—to the point of having speakers tell docs that they could make a million more each year by prescribing the Amgen anemia drug over its competitor, Procrit. http://www.mmm-online.com/amgen-pleads-guilty-takes-cia-in-762-million-false-claims-act-case/article/273559/ Thu, 20 Dec 2012 19:40:46 GMT Amgen "marketed the spread" between the price practices pay for Aranesp and that patients pay as a means of driving sales—to the point of having speakers tell docs that they could make a million more each year by prescribing the Amgen anemia drug over its competitor, Procrit. MMM A federal appeals court has overturned the conviction of a drug rep for detailing a drug off-label on First Amendment grounds, ordering the lower court to retry the case. http://www.mmm-online.com/court-says-off-label-decision-against-jazz-rep-ran-afoul-of-free-speech-protections/article/270987/ Mon, 03 Dec 2012 21:37:39 GMT A federal appeals court has overturned the conviction of a drug rep for detailing a drug off-label on First Amendment grounds, ordering the lower court to retry the case. MMM Elsevier launches new drug class overviews, a whistleblower accuses Abbott and Genzyme clears the way for Lemtrada. http://www.mmm-online.com/company-news-elsevier-abbott-genzyme/article/255671/ Wed, 22 Aug 2012 18:27:44 GMT Elsevier launches new drug class overviews, a whistleblower accuses Abbott and Genzyme clears the way for Lemtrada. MMM The proposed changes center around non-cancer related pain and seek to alter how drug companies can talk about these pain meds. http://www.mmm-online.com/petition-asks-fda-to-set-opioid-marketing-ground-rules/article/252065/ Thu, 26 Jul 2012 18:15:31 GMT The proposed changes center around non-cancer related pain and seek to alter how drug companies can talk about these pain meds. MMM GlaxoSmithKline will pay $3 billion to settle state and federal charges that it promoted antidepressants Paxil and Wellbutrin for unindicated uses and withheld safety data on diabetes drug Avandia. http://www.mmm-online.com/gsk-in-biggest-ever-3b-marketing-fraud-settlement/article/248540/ Mon, 02 Jul 2012 17:09:52 GMT GlaxoSmithKline will pay $3 billion to settle state and federal charges that it promoted antidepressants Paxil and Wellbutrin for unindicated uses and withheld safety data on diabetes drug Avandia. MMM